Stocksigma LogoStocksigma Logo

Thyrocare Divests Radiology Arm Nueclear Healthcare to Trovera for Rs 141.4 Crore

Thyrocare Technologies' board approved divesting 100% of wholly owned subsidiary Nueclear Healthcare Limited to Trovera Healthcare for ~Rs 141.40 cr to

Thyrocare Divests Radiology Arm Nueclear Healthcare to Trovera for Rs 141.4 Crore

Thyrocare Technologies Ltd 路 Others (Uncategorized) 路 21 Sept 2026, 8:32 pm

Thyrocare Divests Radiology Arm Nueclear Healthcare to Trovera for Rs 141.4 Crore Thyrocare Technologies' board approved divesting 100% of wholly owned subsidiary Nueclear Healthcare Limited to Trovera Healthcare for ~Rs 141.40 cr to focus on core pathology. The consideration comprises Rs 81.90 cr in cash (subject to working capital adjustments) and 42,500 CCPS of Trovera valued at Rs 59.50 cr (~4.5% diluted stake). Simultaneously, Thyrocare will acquire operating lab properties in Gurugram and Hyderabad from NHL for Rs 20.59 cr. The transaction requires shareholder approval and is targeted to close by 30th Nov'26.

Original exchange filing (PDF)

More announcements from Thyrocare Technologies Ltd

All Thyrocare Technologies Ltd announcements